RYH

Guggenheim S&P 500® Equal Weight Health Care ETF
NAV $143.81
Change -$2.25 | -1.54%
As Of 1/30/15

Investment Objectives

Seeks to replicate as closely as possible, before fees and expenses, the performance of the S&P 500 Equal Weight Index Health Care.


Net Asset Value

Net Asset Value $143.81
Change -$2.25 | -1.54%


Summary


Ticker RYH
CUSIP 78355W841
Asset Class Sector
Inception Date 11/1/06
Gross Expense Ratio 0.40%
IOPV Ticker RYH.IV
Related Index Ticker S35
Investment Adviser Security Investors, LLC.
Distributor Guggenheim Funds Distributors, LLC.


Profile

Volume 46,888
Last Sale Price $143.85
52-Week Range $147.54 / $109.74
Shares Outstanding 3,350,000
Total Net Assets $481,769,024.11

Market Close

Market Price $143.85
Premium / Discount $0.04
Change -$2.28 | -1.56%
High / Low $146.02 / $143.60


Historical Market Closes to NAV

  Days % of Total Days
Premium 1037 50.00%
Discount 927 44.70%
Equal to NAV 110 5.30%
Total 2,074 100%


Characteristics

Number of Stocks 56
Return on Equity (quarterly 12/31/14) 16.36%
Price to Earning (P/E) 26.54
Price to Book (P/B) 3.53
Dividend Amount $0.15
Ex-Dividend Date N/A

Risk

As of 1/30/15
Standard Deviation Sharpe Ratio Beta R-Squared
10.14 N/A 1.01 99.54

Risk Definitions

Standard Deviation A statistical measure of the historical volatility of an investment, computed using 36 monthly returns. More generally, a measure of the extent to which numbers are spread around their average. The higher the number, the more volatility is to be expected.
Sharpe Ratio A risk-adjusted measure developed by William F. Sharpe, calculated using standard deviation and excess return to determine reward per unit of risk. The higher the Sharpe ratio, the better the fund's risk-adjusted performance.
Beta Beta is a statistical measure of volatility relative to the overall market, usually the S&P 500. A positive beta indicates movement in the same direction as the market, while a negative beta indicates movement inverse to the market. Beta for the market is generally considered to be 1. A beta above 1 or below -1 indicates more volatility than the market. A beta between 1 to -1 indicates less volatility than the market.
R-Squared
A measurement of how closely an investment's performance correlates with the performance of a benchmark, such as the S&P 500, and thus a measurement of what portion of its performance may be explained by the performance of the overall market or index. Values for R-squared range from 0 to 100, where 0 indicates no correlation and 100 indicates perfect correlation.

Overview

as of 1/30/2015
Total Assets $481,769,024
Number of Stocks 56
Percent Stock 99.87%
Percent Cash / Other 0.13%

Sectors / Industries

as of 1/30/15

Holdings

as of 1/30/15

Security Name Ticker Shares
Held
Market
Value
% of Net Assets Sector / Industry
BOSTON SCIENTIFIC CORP BSX 647,413 $9,588,186.53 1.99% Health Care Equipment & Supplies
BIOGEN IDEC, INC. BIIB 24,428 $9,506,400.48 1.97% Biotechnology
LABORATORY CORP OF AMERIC LH 82,577 $9,478,188.06 1.97% Health Care Providers & Services
QUEST DIAGNOSTICS, INC. DGX 132,706 $9,431,415.42 1.96% Health Care Providers & Services
MALLINCKRODT PLC MNK 88,854 $9,417,635.46 1.95% Pharmaceuticals
ANTHEM INC ANTM 68,619 $9,260,820.24 1.92% Health Care Providers & Services
PERKINELMER PKI 201,685 $9,219,021.35 1.91% Life Sciences Tools & Services
VARIAN MEDICAL SYSTEMS IN VAR 98,838 $9,148,445.28 1.90% Health Care Equipment & Supplies
CERNER CORPORATION CERN 136,986 $9,089,021.10 1.89% Health Care Technology
UNITEDHEALTH GROUP INC. UNH 85,220 $9,054,625.00 1.88% Health Care Providers & Services
ENDO INETERNATIONAL PLC ENDP 112,827 $8,982,157.47 1.86% Pharmaceuticals
WATERS CORPORATION WAT 75,443 $8,981,489.15 1.86% Life Sciences Tools & Services
PATTERSON COS INC PDCO 177,409 $8,886,416.81 1.84% Health Care Providers & Services
AETNA INC AET 96,406 $8,851,998.92 1.84% Health Care Providers & Services
ALLERGAN INC AGN 40,372 $8,851,964.72 1.84% Pharmaceuticals
HOSPIRA INC HSP 139,504 $8,848,738.72 1.84% Pharmaceuticals
CIGNA CORPORATION CI 82,728 $8,837,832.24 1.83% Health Care Providers & Services
CARDINAL HEALTH, INC. CAH 106,131 $8,829,037.89 1.83% Health Care Providers & Services
AMERISOURCEBERGEN CORP ABC 92,506 $8,792,695.30 1.83% Health Care Providers & Services
MERCK & COMPANY, INC. MRK 145,814 $8,789,667.92 1.82% Pharmaceuticals
CELGENE CORPORATION CELG 73,508 $8,759,213.28 1.82% Biotechnology
MCKESSON CORPORATION MCK 40,988 $8,716,098.20 1.81% Health Care Providers & Services
ELI LILLY & COMPANY LLY 121,010 $8,712,720.00 1.81% Pharmaceuticals
ACTAVIS PLC ACT 32,496 $8,661,483.84 1.80% Pharmaceuticals
BRISTOL MYERS SQUIBB CO BMY 143,255 $8,633,978.85 1.79% Pharmaceuticals
ABBOTT LABORATORIES ABT 192,640 $8,622,566.40 1.79% Health Care Equipment & Supplies
ZOETIS INC ZTS 201,492 $8,609,753.16 1.79% Pharmaceuticals
DAVITA, INC DVA 114,662 $8,606,529.72 1.79% Health Care Providers & Services
C.R. BARD, INC. BCR 50,251 $8,594,428.53 1.78% Health Care Equipment & Supplies
HUMANA, INC. HUM 58,608 $8,582,555.52 1.78% Health Care Providers & Services
PFIZER INC PFE 271,934 $8,497,937.50 1.76% Pharmaceuticals
BECTON DICKINSON & CO BDX 61,437 $8,483,220.96 1.76% Health Care Equipment & Supplies
CAREFUSION CORP CFN 142,986 $8,479,069.80 1.76% Health Care Equipment & Supplies
ZIMMER HOLDINGS INC ZMH 75,589 $8,473,526.90 1.76% Health Care Equipment & Supplies
GILEAD SCIENCES, INC. GILD 80,821 $8,472,465.43 1.76% Biotechnology
THERMO FISHER SCIENTIFIC TMO 67,334 $8,430,890.14 1.75% Life Sciences Tools & Services
REGENERON PHARMACEUTICALS REGN 20,208 $8,419,865.28 1.75% Biotechnology
MYLAN INC. MYL 157,845 $8,389,461.75 1.74% Pharmaceuticals
ST. JUDE MEDICAL INC. STJ 126,884 $8,357,849.08 1.73% Health Care Equipment & Supplies
STRYKER CORP SYK 91,480 $8,329,254.00 1.73% Health Care Equipment & Supplies
PERRIGO COMPANY PRGO 54,859 $8,324,304.66 1.73% Pharmaceuticals
HCA HOLDINGS INC HCA 117,209 $8,298,397.20 1.72% Health Care Providers & Services
MEDTRONIC PLC MDT 116,054 $8,286,255.60 1.72% Health Care Equipment & Supplies
INTUITIVE SURGICAL, INC. ISRG 16,735 $8,275,122.80 1.72% Health Care Equipment & Supplies
ALEXION PHARMACEUTICALS I ALXN 45,027 $8,250,747.48 1.71% Biotechnology
BAXTER INTERNATIONAL BAX 117,264 $8,244,831.84 1.71% Health Care Equipment & Supplies
EXPRESS SCRIPTS HLDGS ESRX 101,547 $8,195,858.37 1.70% Health Care Providers & Services
EDWARDS LIFESCIENCES CORP EW 65,309 $8,186,483.15 1.70% Health Care Equipment & Supplies
UNIVERSAL HEALTH SERVICES UHS 78,923 $8,091,975.19 1.68% Health Care Providers & Services
JOHNSON & JOHNSON JNJ 80,592 $8,070,482.88 1.68% Pharmaceuticals
AGILENT TECHNOLOGIES, INC A 211,889 $8,003,047.53 1.66% Life Sciences Tools & Services
VERTEX PHARMACEUTICALS VRTX 70,993 $7,819,169.02 1.62% Biotechnology
AMGEN INC. AMGN 51,149 $7,787,946.74 1.62% Biotechnology
ABBVIE INC-W/I ABBV 128,945 $7,781,830.75 1.62% Pharmaceuticals
DENTSPLY INTERNATIONAL XRAY 155,255 $7,766,631.38 1.61% Health Care Equipment & Supplies
TENET HEALTHCARE CORP THC 167,488 $7,081,392.64 1.47% Health Care Providers & Services
FEDERATED US TREAS CASH RESERVE INSTITUTIONAL 1,685,354 $1,685,353.55 0.35% na

Disclosure

Performance displayed represents past performance, which is no guarantee of future results. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Total returns reflect the reinvestment of all dividends. Current performance may be lower or higher than the performance data quoted. For up-to-date fund performance, including performance current to the most recent month-end, please visit the ETF performance page. ETFs are subject to third party transaction fees/commissions. Net asset value (NAV) is calculated by subtracting total liabilities from total assets, then dividing by the number of shares outstanding. Market close is the last price at which shares are traded. Fund shares may trade at, above or below NAV. For additional information, see the fund’s prospectus.

Performance results for periods under one year are short-term and may not provide an adequate basis for evaluating the performance potential of the fund over varying market conditions or economic cycles.

Sector funds may not be suitable for all investors. Investing in sector funds is more volatile than investing in broadly diversified funds, as there is a greater risk due to the concentration of the funds' holdings in issuers of similar offerings. Guggenheim Investment Equal Weight ETFs may not be suitable for all investors. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Most investors will also incur customary brokerage commissions when buying or selling shares of an ETF. Investments in securities are subject to market risks that may cause their prices to fluctuate over time. Please review a prospectus carefully for more information of the risks associated with each ETF.

Fund data is subject to change on a daily basis.

Composition is subject to change. Information provided is for illustration purposes only and may not reflect current investments by the fund. Referenced companies are not affiliated with Guggenheim Investments and Guggenheim Investments does not sponsor, endorse, sell or promote the referenced companies.

“Standard & Poor’s®”, “S&P®”, “S&P 500®”, “Standard & Poor’s 500”, “500”, “S&P MidCap 400” and “S&P SmallCap 600” are trademarks of Standard & Poor’s, LLC and have been licensed for use by Guggenheim Investments and its affiliates. Citigroup is a trademark of Citigroup Global Markets Inc. and has been licensed for use by Standard & Poor’s. The product is not sponsored, endorsed, sold or promoted by Standard & Poor’s, and neither Standard & Poor’s nor Citigroup Global Markets Inc. makes no representation regarding the advisability of investing in the product.
 

Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objectives, risks, charges, expenses and other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or contact us.

Guggenheim Investments represents the investment management businesses of Guggenheim Partners, LLC ("Guggenheim"), which includes Security Investors, LLC ("SI"), Guggenheim Funds Investment Advisors, LLC, ("GFIA") and Guggenheim Partners Investment Management ("GPIM") the investment advisers to the referenced funds. Securities offered through Guggenheim Funds Distributors, LLC, an affiliate of Guggenheim, SI, GFIA and GPIM.

Guggenheim

Subscribe to Perspectives

 

©2015 Guggenheim Investments. All Rights Reserved.

• Not FDIC Insured • No Bank Guarantee • May Lose Value